References
F. T. Bosman, F. Carneiro, R. H. Hruban, and N. D. Theise, “WHO classification of tumours of the digestive system.,” WHO Classif. tumours Dig. Syst., no. Ed. 4, 2010.
J. R. Hyngstrom et al., “Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: Analysis from the National Cancer Data Base,” Ann. Surg. Oncol., vol. 19, no. 9, pp. 2814–2821, Sep. 2012, doi: https://doi.org/10.1245/s10434-012-2321-7.
R. Habib et al., “Is mucinous histology a prognostic marker in early and advanced colorectal cancer?,” J. Clin. Oncol., vol. 38, no. 4_suppl, pp. 253–253, Feb. 2020, doi: https://doi.org/10.1200/jco.2020.38.4_suppl.253.
K. Inamura et al., “Prognostic Significance and Molecular Features of Signet-Ring Cell and Mucinous Components in Colorectal Carcinoma,” Ann. Surg. Oncol., vol. 22, no. 4, pp. 1226–1235, Mar. 2015, doi: https://doi.org/10.1245/s10434-014-4159-7.
M. Numata et al., “The clinicopathological features of colorectal mucinous adenocarcinoma and a therapeutic strategy for the disease,” World J. Surg. Oncol., vol. 10, no. 1, p. 109, Jun. 2012, doi: https://doi.org/10.1186/1477-7819-10-109.
S. O. Yun et al., “Clinical significance of signet-ring-cell colorectal cancer as a prognostic factor,” Ann. Coloproctol., vol. 33, no. 6, pp. 232–238, Dec. 2017, doi: https://doi.org/10.3393/ac.2017.33.6.232.
Author information
Authors and Affiliations
Contributions
• YZQ: contributed to the study design, acquisition, analysis, and interpretation of data; has drafted the manuscript; and approved of the final version to be published and agrees to be accountable for all aspects of the work
• NMS: contributed to the study design, interpretation of data, and critical revision; approved of the final version to be published; and agrees to be accountable for all aspects of the work
• CB: contributed to the acquisition of data and critical revision; approved of the final version to be published; and agrees to be accountable for all aspects of the work
• HK: contributed to the study design, interpretation of data, and critical revision; approved of the final version to be published; and agrees to be accountable for all aspects of the work
• RNG: contributed to the study design, interpretation of data, and critical revision; approved of the final version to be published; and agrees to be accountable for all aspects of the work
• RR: contributed to the study design, interpretation of data, and critical revision; approved of the final version to be published; and agrees to be accountable for all aspects of the work
• DLB: contributed to the study design, acquisition, and interpretation of data; approved of the final version to be published; and agrees to be accountable for all aspects of the work
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Qwaider, .Z., Sell, N.M., Stafford, C.E. et al. Prognosis of Different Histological Types in Patients with Stage II and III Colon Cancer. J Gastrointest Surg 26, 476–478 (2022). https://doi.org/10.1007/s11605-021-05091-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-021-05091-1